NetworkNewsBreaks Archive - Page 436 of 1740

ThursdayMar 31, 2022 12:16 pm

NetworkNewsBreaks – Lottery.com (NASDAQ: LTRY) Releases Q4, Full-Year Results

Lottery.com (NASDAQ: LTRY), a leading technology company that is transforming how, where and when the lottery is played, is reporting its fourth-quarter and full-year 2021 revenue for the period ending Dec. 31, 2021. Q4 revenue totaled $21.5 million, an increase of $18.2 million over the previous year, with full-year revenue of $68.5 million, an increase of $61 million over 2020 numbers. The company also reported full-year 2021 pro forma revenue of $70.5 million, including acquired interest in Mexican entities, with full-year 2021 net loss of $9.3 million and adjusted EBITDA of $31.1 million. Corporate highlights include the company’s successful completion…

ThursdayMar 31, 2022 11:21 am

NetworkNewsBreaks – Silo Pharma Inc. (SILO) Enters Agreement to Significantly Advance Technologies ‘Closer to the Clinic’

Silo Pharma (OTCQB: SILO) is a developmental stage biopharmaceutical company focused on the use of psychedelics as a therapeutic. Silo Pharma today announced its entry into an agreement with Frontage Laboratories, a contract research organization (“CRO”) providing integrated, science-driven, product development services throughout the drug discovery and development process that enable life science companies to achieve their drug development goals. “This agreement significantly advances our Central Nervous System Peptide, SPU-16, and our Joint Homing Peptide, SPU-21 technologies closer to the clinic,” said Eric Weisblum, CEO of Silo Pharma. “These solutions have the potential to enhance the therapeutic effect of current…

ThursdayMar 31, 2022 11:12 am

NetworkNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Announces New Clinic Openings as Company’s Expansion Accelerates

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, is opening Ketamine Wellness Centers (“KWC”) in Salt Lake City and Reno, Nevada, with additional locations planned to open this year. The company also announced that it is adding SPRAVATO(R), the first FDA-approved nasal spray, as a treatment option at three of its ketamine centers; the spray is intended to treat adults with treatment-resistant depression and depressive symptoms of major depressive disorder. In addition, the the company’s Delic Labs received Health Canada 56 exemptions to perform research and development work for several substances, including MDMA,…

WednesdayMar 30, 2022 2:41 pm

NetworkNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Poised to Increase Overall Value on the Lightning Network

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network, recently deployed additional European routing nodes. “The company’s available European routing nodes include Italy, Sweden, England, Ireland, France, and Germany. Europe contains approximately 43% of all Lightning Network nodes – second to North America,” a recent article reads. Since the November 2021 launch of the first routing node, US-West, LQwD has seen 157 nodes interconnected with more than 158 transaction channels, routing over 10 Bitcoin through these channels. “LQwD’s launch of these additional nodes firmly positions us to increase…

WednesdayMar 30, 2022 2:29 pm

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) 24th Patent Sets the Stage for New Market Opportunities in Australia

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, celebrated the receipt of its 24th granted patent entitled “Compositions Infused with Nicotine Compounds and Methods of Use Thereof.” Granted in Australia, this is the first patent awarded from the company’s 8th patent family. “The new patent expands on the company’s international IP rights to apply DehydraTECH(TM) technology to most forms of nicotine, namely sprays, gums, lozenges, pouches, capsules, tablets, and pills. It also covers multiple disparate forms of nicotine, including polymer resins of nicotine, freebase nicotine and other nicotine complexes,” reads a recent article. Prior to the…

WednesdayMar 30, 2022 1:47 pm

NetworkNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Releases Spring 2022 Robot Roadshow Schedule

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced its spring 2022 Robot Roadshow schedule. Designed to be an engaging experiential event that allows Knightscope to connect with potential clients and showcase its proprietary crime-fighting robots, the Robot Roadshow will begin on April 12, 2022, and will tour 10 states, including Minnesota, Wisconsin, Illinois, Indiana and Ohio, with 35 scheduled stops. The roadshow will also be in Washington, D.C. during National Police Week. Creative marketing events such as the Robot Roadshow allow KSCP, a public safety innovator, to educate existing and…

WednesdayMar 30, 2022 1:35 pm

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) to Host LD Micro Invitational at Four Seasons Westlake Village

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced that it will host the 2022 LD Micro Invitational. The prominent three-day investor conference is slated to take place on June 7-9, 2022, at the Four Seasons Hotel Westlake Village, California. Approximately 200 companies from all over the world will showcase what makes them truly special at the event, each presenting for 25 minutes and finalizing their exhibition with private meetings. SRAX will soon release the link to register for virtual and physical components of the…

WednesdayMar 30, 2022 1:26 pm

NetworkNewsBreaks – Advisors Mortgage Group LLC’s President Named Among 2022 NJBIZ Leaders in Finance

Advisors Mortgage Group, based in Ocean Township, New Jersey, today announced that the company’s President Steven Meyer was named one of the honorees of the 2022 NJBIZ Leaders in Finance awards. The awards celebrate New Jersey’s financial executives at all levels who contribute to the success of their companies and communities. According to information from NJBIZ, honorees were chosen by a panel of independent judges with experience in the financial field following an open nomination period. The selections were based on the nominees’ involvement in their industries and communities, as well as their achievements, energy and innovative ideas. “I am…

WednesdayMar 30, 2022 1:04 pm

NetworkNewsBreaks – Feed Every Gorilla Eyes the Coming Year as ‘One for the History Books’

Since its launch in early 2021, the Feed Every Gorilla (“FEG”) Token project has repeatedly exceeded expectations, rapidly pushing out next-gen tech. Some of the revolutionary technologies laying the foundation for the next phase of growth and expansion include the decentralized and community-owned FEG Exchange (“FEGex”), the honey pot-proof SmartSwap system, the second-to-none fWrapping system and the groundbreaking SmartDeFi cryptocurrency launchpad. After closing out its first hugely successful year, the FEG project will turn heads and change crypto forever with its roadmap expansion. The recent announcement of upcoming technology releases will undoubtedly catapult FEG into the forefront, further demonstrating the…

WednesdayMar 30, 2022 1:00 pm

NetworkNewsBreaks – Delic Holdings Corp.’s (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Subsidiary Expands Treatment Options to Add FDA-Approved Esketamine Nasal Spray

Delic Holdings’ (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) subsidiary, Ketamine Wellness Centers (“KWC”), the largest ketamine therapy provider in the U.S., has expanded its treatment options to include SPRAVATO(R) nasal spray. KWC clinics located in Houston, Las Vegas and Seattle will begin offering this treatment option on April 1. According to the announcement, SPRAVATO is taken with an oral antidepressant and is the first FDA-approved esketamine nasal spray for adults with treatment-resistant depression (“TRD”) or to treat depressive symptoms in adults with major depressive disorder (“MDD”) with suicidal thoughts or actions. Patients interested in the treatment option will first undergo…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

NetworkNewsBreaks